Stoke Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 76k | 23.50 |
| 2025-06-30 | $1.2M | 107k | 11.35 |
| 2025-03-31 | $551k | 83k | 6.65 |
| 2024-12-31 | $1.1M | 96k | 11.03 |
| 2024-09-30 | $525k | 43k | 12.29 |
| 2024-06-30 | $776k | 57k | 13.51 |
| 2023-09-30 | $45k | 11k | 3.94 |
| 2023-06-30 | $95k | 11k | 8.33 |
| 2023-03-31 | $95k | 11k | 8.33 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas